See how your profile stacks up against this role.
We compared the job requirements to your profile to show where you're strong and where you fall short.
This is an early, high-ownership engineering position on a small product team at a well-funded healthtech startup. You'll be one of the first engineers focused on chat and real-time features, working directly alongside founding stakeholders to shape core systems that define the user experience and product direction. This is a rare opportunity to have lasting technical impact from day one.
Design and implement core chat and real-time features for a production healthtech product.
Collaborate closely with a small, cross-functional founding team to define and execute technical direction.
Build reliable, scalable services and iterate quickly based on real user feedback.
Participate in architecture and design discussions, balancing speed-to-ship with long-term maintainability.
Own components end-to-end — from implementation and testing through to monitoring and observability.
Proven track record delivering production software in real-time or chat-related systems.
Strong engineering fundamentals with practical, full-stack experience building scalable, reliable services.
Comfort operating with high autonomy in a fast-moving, early-stage environment.
Experience collaborating effectively in remote or distributed teams.
Must be a U.S. citizen or Green Card holder — visa sponsorship is not available now or in the future.
Base salary: $135,000 – $155,000 per year
Equity: ~0.5% – 1.5%
Opportunity to shape the technical foundation of a high-growth healthtech product
Fully remote within the United States. Candidates must be based in the U.S. and authorized to work without visa sponsorship.
After you apply, unlock the direct contact details of the people who actually make the call. A quick follow-up makes you 5x more likely to land an interview.
Marcus Rivera
Chief Revenue Officer

Blue Star Families

WellSky

Signature Analytics

Array

Stack Exchange, Inc.

Clera Inc.

Clera Inc.

Clera Inc.